Sodium aurothiosulfate
From Wikidoc - Reading time: 3 min
2.png) | |
-thiosulfate-dihydrate-unit-cell-3D-balls.png) | |
| Clinical data | |
|---|---|
| Routes of administration | Intramuscular injection |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | AuNa3O6S4 |
| Molar mass | 332.08452 g/mol |
| (verify) | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview[edit | edit source]
Sodium aurothiosulfate is the inorganic compound with the formula Na3Au(S2O3)2·2H2O. This salt contains an anionic linear coordination complex of gold(I) bound to two thiosulfate ligands.[1][2] Like several other gold compounds, this species is used as an antirheumatic.[3]The first placebo-controlled trial was probably conducted in 1931, when sanocrysin was compared with distilled water for the treatment of tuberculosis.[4]
References[edit | edit source]
- ↑ Baggio, R (1973). "Crystal and molecular structure of trisodium dithiosulphate aurate(I), dihydrate, Na3[Au(S2O3)2],2H2O". Journal of Inorganic and Nuclear Chemistry. 35 (9): 3191. doi:10.1016/0022-1902(73)80019-3.
- ↑ Tobön-Zapata, G (1997). "Vibrational spectrum of Sanocrysin". Spectrochimica Acta Part a Molecular and Biomolecular Spectroscopy. 53 (2): 183. doi:10.1016/S1386-1425(97)83024-7.
- ↑ Shaw, III, C. F. (1999). "Gold-Based Therapeutic Agents". Chemical Reviews. 99 (9): 2589–600. doi:10.1021/cr980431o. PMID 11749494.
- ↑ Ethical and regulatory aspects of clinical research: readings and commentary, Ezekiel J. Emanuel, Johns Hopkins University Press, 2003, p 140
Licensed under CC BY-SA 3.0 | Source: https://www.wikidoc.org/index.php/Sodium_aurothiosulfate7 views | Status: cached on October 04 2025 17:21:21↧ Download this article as ZWI file
EncycloReader
is supported by the 
KSF